Zaloguj Zarejestruj się zadarmo

Acorda Therapeutics Inc organizacji Wskaźnik krótkiej sprzedaży

Jaka jest wartość Wskaźnik krótkiej sprzedaży organizacji Acorda Therapeutics Inc?

Wartość Wskaźnik krótkiej sprzedaży organizacji Acorda Therapeutics Inc to 0.25

Jaka jest definicja Wskaźnik krótkiej sprzedaży?



Wskaźnik krótkiej sprzedaży (Short ratio) to liczba akcji sprzedanych na krótko podzielona przez średnią wartość dzienną.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Wskaźnik krótkiej sprzedaży firm w Health Care sektor na NASDAQ w porównaniu do Acorda Therapeutics Inc

Czym się zajmuję organizacja Acorda Therapeutics Inc?

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

Firmy z wskaźnik krótkiej sprzedaży podobne do Acorda Therapeutics Inc